Prevention of Hepatitis B reactivation in the setting of immunosuppression
Advances in the treatment of malignant and inflammatory diseases have developed over time, with increasing use of chemotherapeutic and immunosuppressive agents of a range of drug classes with varying mechanism and potency in their effects on the immune system. These advances have been met with the c...
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
Korean Association for the Study of the Liver
2016-06-01
|
Series: | Clinical and Molecular Hepatology |
Subjects: | |
Online Access: | http://e-cmh.org/upload/pdf/cmh-2016-0024.pdf |